Last week, Moderna and Pfizer began Phase 3 human clinical trials for experimental coronavirus vaccines. While there have been policy efforts to fast-track the development of COVID-19 treatments, many public health officials agree that more deaths will be unavoidable unless there is a vaccine is created. Earlier this year, the Trump Administration launched Operation Warp Speed (OWS) to shorten the development timeline, investing in the future of half a dozen potential vaccines. The Administration has also begun to commit buying millions of doses of vaccines still in in development, should they be proven effective, which will help make the vaccines available in large quantities. Will the government’s efforts be enough to produce a timely vaccine?

Open document to read more; page 2.

View PDF